chalcone has been researched along with Hyperlipemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, HJ; Jin, WF; Li, M; Li, XH; Yu, L; Zhang, YY; Zhou, J | 1 |
Fan, H; Jin, W; Li, M; Li, X; Zhang, Y; Zhou, J | 1 |
Bhatia, G; Dodda, RP; Palnati, GR; Sashidhara, KV; Sonkar, R | 1 |
Agula, B; Bao, LD; Lv, HJ; Ma, RL; Ren, XH; Wang, Y | 1 |
Cai, D; Fang, W; Feng, Y; Han, D; Li, Y; Ma, W; Shen, C; Wei, J; Xia, N; Xu, D; Zhang, R | 1 |
5 other study(ies) available for chalcone and Hyperlipemia
Article | Year |
---|---|
[Pharmacokinetics-pharmacodynamics correlation of protocatechuic aldehyde and hydroxysafflor yellow A alone or their combination use in rats with hyperlipidemia].
Topics: Animals; Benzaldehydes; Catechols; Chalcone; Hyperlipidemias; Quinones; Rats | 2017 |
Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia.
Topics: Animals; Anticoagulants; Benzaldehydes; Cardiotonic Agents; Catechols; Chalcone; Drugs, Chinese Herbal; Hyperlipidemias; Lipids; Male; Quinones; Random Allocation; Rats; Rats, Sprague-Dawley | 2018 |
Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Topics: Animals; Antioxidants; Chalcone; Disease Models, Animal; Drug Design; Hyperlipidemias; Hypolipidemic Agents; Indoles; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Molecular Structure; Polyethylene Glycols; Rats | 2014 |
Hypolipidemic effect of safflower yellow and primary mechanism analysis.
Topics: Amphotericin B; Animals; Cell Survival; Chalcone; CHO Cells; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Cricetulus; Hyperlipidemias; Hypolipidemic Agents; Liver; Mice; Triglycerides | 2015 |
Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
Topics: Animals; Anti-Inflammatory Agents; Chalcone; Diet, High-Fat; Gene Expression Regulation; Hyperlipidemias; Interleukin-1beta; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; Mice; Mice, Knockout; Myocardial Reperfusion Injury; Myocytes, Cardiac; NF-kappa B; Primary Cell Culture; Quinones; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2016 |